Skip to content

Efficacy of Auricular Therapy in preventing Intrapartum Fever during Labor Analgesia: A Single-Center, Double-Blind ,Randomized Controlled Trial

A Clinical Study on Auricular Therapy for Intrapartum Fever during Labor Analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121744
Enrollment
Unknown
Registered
2026-04-02
Start date
2025-09-03
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrapartum fever

Interventions

Auricular Therapy Group:Adhere Vaccaria seed auricular point patches to the corresponding acupoints on the right ear of the puerpera and perform pressing according to the protocol.
Control Group:Adhere sham auricular point patches (with the Vaccaria seeds removed) to the same acupoints and perform pressing in accordance with the protocol.

Sponsors

Women's Hospital of Nanjing Medical University,Nanjing Women and Children's Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. ASA Physical Status Class I-II 2. Age 18-40 years 3. Body mass index (BMI) =37 weeks 5. Primiparous women with singleton cephalic presentation 6. Request for epidural analgesia at cervical dilation <=3 cm 7. Afebrile status (<=37.2°C) upon labor room admission and no febrile history within one week 8. Absence of contraindications to epidural anesthesia 9. Without hypertensive disorders of pregnancy 10. Normal fetal heart rate monitoring prior to analgesia (120-160 bpm)

Exclusion criteria

Exclusion criteria: 1. Cephalopelvic disproportion or pelvic deformities 2. Cervical dilation >3 cm at the time of labor analgesia request 3. Contraindications to neuraxial anesthesia (e.g. coagulopathy local infection at puncture site) 4. Opioid or other sedative/analgesic use within one week 5. Current magnesium sulfate administration 6. History of substance abuse 7. Severe cardiopulmonary/hepatic/renal dysfunction 8. Active infection within two weeks or recent antibiotic use

Design outcomes

Primary

MeasureTime frame
Incidence of intrapartum fever;

Secondary

MeasureTime frame
Maternal temperature ;Pain NRS;analgesic consumption and PCEA attempts;duration and method of membrane rupture;number of vaginal examinations;Delivery usage rate;Duration of delivery;Incidence of abnormal fetal heart rate;Mode of delivery;Perineal laceration and episiotomy rate;Amount of bleeding;Neonatal Apgar score;Neonatal transfer rate to NICU;Maternal satisfaction;Others (frequency of sweating, urination, and vomiting) ;Concentrations of inflammatory factors (IL-6, IL-1ß, and TNF-a);

Countries

China

Contacts

Public ContactXu Shiqin

Women's Hospital of Nanjing Medical University,Nanjing Women and Children's Healthcare Hospital

xusqnj@126.com+86 139 5166 0028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026